Organization
Tulane University
10 clinical trials
Clinical trial
Refining Treatment Options for Trichomonas Vaginalis Infection in Women and Men: A Comparative Analysis of Oral Multi-Dose Metronidazole and Single-Dose SecnidazoleStatus: Not yet recruiting, Estimated PCD: 2029-05-01
Clinical trial
The Use of Ultrasound-Guided Dextrose Prolotherapy in Low Back Pain in Patients With Hypermobile-Type, Ehlers-Danlos SyndromeStatus: Not yet recruiting, Estimated PCD: 2025-09-01
Clinical trial
An in Vitro Pilot Study of the Role of Factor IX as an Alternative to Bypassing Agents in the Treatment of Breakthrough Bleeds in Patients With Hemophilia A and Inhibitors Treated With Emicizumab.Status: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
Testosterone TReatment for Erectile Dysfunction in Male Multiple Sclerosis Patients With Low Testosterone (TTRED-MS Study)Status: Not yet recruiting, Estimated PCD: 2024-12-01
Clinical trial
Acute Estradiol and Progesterone Therapy in Hospitalized Adults to Reduce Coronavirus Disease (COVID-19) Severity: A Randomized Control TrialStatus: Terminated, Estimated PCD: 2022-01-25
Clinical trial
The Effect of Lumify™ (Brimonidine Tartrate Ophthalmic Solution 0.025%) on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients Using Brimonidine 0.2%, 0.15%, or 0.1%Status: Not yet recruiting, Estimated PCD: 2030-06-01
Clinical trial
Changes in 18F-fluciclovine Positron Emission Tomography (PET) in Patients With Metastatic Castration Resistant Prostate Cancer Treated With With Life Prolonging Therapies: A Pilot StudyStatus: Completed, Estimated PCD: 2022-09-30
Clinical trial
An Open-Label, Case-Control Study to Compare the Anamnestic Response to the Recombinant Vesicular Stomatitis Delta Glycoprotein Zaire Ebola Virus (ZEBOV) Glycoprotein (rVSVDG-ZEBOV-GP) Ebola Virus Vaccine Among Ebola Virus Disease Survivors to the Primary Immune Response Among Naïve Age and Sex-Matched ControlsStatus: Not yet recruiting, Estimated PCD: 2025-03-01
Clinical trial
A Phase 2, Open Label Single Arm Study for Evaluating Safety & Efficacy of Apremilast in the Treatment of Cutaneous Disease in Patients With Recalcitrant DermatomyositisStatus: Completed, Estimated PCD: 2021-02-28